PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-74.25%
Both yoy net incomes decline, with CRK at -11.63%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-1.52%
Both reduce yoy D&A, with CRK at -90.29%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
94.57%
Some yoy growth while CRK is negative at -4.68%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
350.00%
SBC growth while CRK is negative at -3.13%. John Neff would see competitor possibly controlling share issuance more tightly.
470.37%
Well above CRK's 242.54% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
470.37%
Growth well above CRK's 402.31%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
268.18%
Lower 'other non-cash' growth vs. CRK's 734.82%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
68.77%
Operating cash flow growth below 50% of CRK's 815.02%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-0.31%
Both yoy lines negative, with CRK at -66.07%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-83.65%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
3013.64%
Purchases growth of 3013.64% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-91.24%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
3.68%
We have some outflow growth while CRK is negative at -100.02%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-43.80%
Both yoy lines negative, with CRK at -116.70%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
100.00%
Debt repayment similar to CRK's 100.00%. Walter Schloss sees parallel liability management or similar free cash flow availability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.